annual CFI:
-$2.25B+$5.28B(+70.08%)Summary
- As of today (June 22, 2025), BNTX annual cash flow from investing activities is -$2.25 billion, with the most recent change of +$5.28 billion (+70.08%) on December 31, 2024.
- During the last 3 years, BNTX annual CFI has fallen by -$1.58 billion (-236.31%).
- BNTX annual CFI is now -5950.91% below its all-time high of -$37.23 million, reached on December 31, 2022.
Performance
BNTX Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$1.31B+$608.33M(+86.46%)Summary
- As of today (June 22, 2025), BNTX quarterly cash flow from investing activities is $1.31 billion, with the most recent change of +$608.33 million (+86.46%) on March 1, 2025.
- Over the past year, BNTX quarterly CFI has increased by +$3.81 billion (+152.41%).
- BNTX quarterly CFI is now at all-time high.
Performance
BNTX quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$1.56B+$3.81B(+169.36%)Summary
- As of today (June 22, 2025), BNTX TTM cash flow from investing activities is $1.56 billion, with the most recent change of +$3.81 billion (+169.36%) on March 1, 2025.
- Over the past year, BNTX TTM CFI has increased by +$10.80 billion (+116.90%).
- BNTX TTM CFI is now at all-time high.
Performance
BNTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
BNTX Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +70.1% | +152.4% | +116.9% |
| 3 y3 years | -236.3% | +306.8% | +598.8% |
| 5 y5 years | -2506.4% | +8078.7% | +2496.6% |
BNTX Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -5950.9% | +70.1% | at high | +145.4% | at high | +116.9% |
| 5 y | 5-year | -5950.9% | +70.1% | at high | +145.4% | at high | +116.9% |
| alltime | all time | -5950.9% | +70.1% | at high | +145.4% | at high | +116.9% |
BNTX Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $1.31B(+86.5%) | $1.56B(-169.4%) |
| Dec 2024 | -$2.25B(-70.1%) | $703.59M(-427.3%) | -$2.25B(-61.5%) |
| Sep 2024 | - | -$214.99M(-9.7%) | -$5.85B(-16.1%) |
| Jun 2024 | - | -$238.16M(-90.5%) | -$6.97B(-24.6%) |
| Mar 2024 | - | -$2.50B(-13.4%) | -$9.24B(+22.8%) |
| Dec 2023 | -$7.53B(>+9900.0%) | -$2.89B(+116.3%) | -$7.53B(+56.8%) |
| Sep 2023 | - | -$1.34B(-46.8%) | -$4.80B(+34.8%) |
| Jun 2023 | - | -$2.51B(+217.9%) | -$3.56B(+209.8%) |
| Mar 2023 | - | -$789.85M(+382.0%) | -$1.15B(+2988.0%) |
| Dec 2022 | -$37.23M(-94.4%) | -$163.85M(+70.7%) | -$37.23M(-672.3%) |
| Sep 2022 | - | -$95.99M(-3.9%) | $6.51M(-101.7%) |
| Jun 2022 | - | -$99.88M(-131.0%) | -$377.16M(+20.4%) |
| Mar 2022 | - | $322.50M(-368.5%) | -$313.20M(-53.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$669.80M(+305.0%) | -$120.12M(-75.0%) | -$669.80M(+1.1%) |
| Sep 2021 | - | -$479.66M(+1235.4%) | -$662.42M(+218.2%) |
| Jun 2021 | - | -$35.92M(+5.3%) | -$208.18M(+13.7%) |
| Mar 2021 | - | -$34.10M(-69.8%) | -$183.02M(+10.7%) |
| Dec 2020 | -$165.37M(+91.3%) | -$112.74M(+343.5%) | -$165.37M(+156.4%) |
| Sep 2020 | - | -$25.42M(+136.3%) | -$64.50M(+3.7%) |
| Jun 2020 | - | -$10.76M(-34.6%) | -$62.21M(-4.6%) |
| Mar 2020 | - | -$16.44M(+38.5%) | -$65.19M(-24.6%) |
| Dec 2019 | -$86.43M(+10.1%) | -$11.88M(-48.7%) | -$86.43M(+15.9%) |
| Sep 2019 | - | -$23.14M(+68.4%) | -$74.55M(+45.0%) |
| Jun 2019 | - | -$13.74M(-63.5%) | -$51.41M(+36.5%) |
| Mar 2019 | - | -$37.68M | -$37.68M |
| Dec 2018 | -$78.47M(+31.9%) | - | - |
| Dec 2017 | -$59.51M | - | - |
FAQ
- What is BioNTech SE annual cash flow from investing activities?
- What is the all time high annual CFI for BioNTech SE?
- What is BioNTech SE annual CFI year-on-year change?
- What is BioNTech SE quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for BioNTech SE?
- What is BioNTech SE quarterly CFI year-on-year change?
- What is BioNTech SE TTM cash flow from investing activities?
- What is the all time high TTM CFI for BioNTech SE?
- What is BioNTech SE TTM CFI year-on-year change?
What is BioNTech SE annual cash flow from investing activities?
The current annual CFI of BNTX is -$2.25B
What is the all time high annual CFI for BioNTech SE?
BioNTech SE all-time high annual cash flow from investing activities is -$37.23M
What is BioNTech SE annual CFI year-on-year change?
Over the past year, BNTX annual cash flow from investing activities has changed by +$5.28B (+70.08%)
What is BioNTech SE quarterly cash flow from investing activities?
The current quarterly CFI of BNTX is $1.31B
What is the all time high quarterly CFI for BioNTech SE?
BioNTech SE all-time high quarterly cash flow from investing activities is $1.31B
What is BioNTech SE quarterly CFI year-on-year change?
Over the past year, BNTX quarterly cash flow from investing activities has changed by +$3.81B (+152.41%)
What is BioNTech SE TTM cash flow from investing activities?
The current TTM CFI of BNTX is $1.56B
What is the all time high TTM CFI for BioNTech SE?
BioNTech SE all-time high TTM cash flow from investing activities is $1.56B
What is BioNTech SE TTM CFI year-on-year change?
Over the past year, BNTX TTM cash flow from investing activities has changed by +$10.80B (+116.90%)